Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 5, 1999, Pages 436-445

  Winther, Lone ^a   Moseholm, L ^b   Reimert, C M ^a   Skov, P Stahl ^a   Poulsen, L Kærgaard ^a  

^a Rigshospitalet   (Denmark)

^b The Danish Environmental Protection Agency EPA   (Denmark)

Author keywords

Allergic rhinitis; Basophil histamine release; Eosinophil cationic protein; Eosinophil protein X; Eosinophils; Specific IgE

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E;

ADULT; ALLERGIC RHINITIS; ARTICLE; BASOPHIL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BASOPHILS; BLOOD PROTEINS; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; FEMALE; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; POLLEN; RHINITIS, ALLERGIC, SEASONAL; RIBONUCLEASES; SEASONS; SEVERITY OF ILLNESS INDEX;

EID: 0033051231     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00910.x     Document Type: Article

References (36)

1. Durham SR, Vamey V, Gaga M, et al. Immunotherapy and allergic inflammation. Clin Exp Allergy 1991;21:206-210.
2. Andersson M, Svensson C, Andersson P, Pipkorn U. Objective monitoring of the allergic inflammatory response of the nasal mucosa in patients with hay fever during natural allergen exposure. Am Rev Respir Dis 1989;139:911-914.
3. Fling JA, Ruff ME, Parker WA, et al. Suppression of the late cutaneous response by immunotherapy. J Allergy Clin Immunol 1989;83:101-109.
4. Furin MJ, Norman PS, Creticos PS, et al. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 1991;88:27-32.
5. Petersen BN, Janniche H, Munch EP, et al. Immunotherapy with partially purified and standardized tree pollen extracts. Allergy 1988;43:353-362.
6. Bascom R, Pipkom U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis 1988;138:406-412.
7. Durham SR, Sun Y, Vamey VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-2394.
8. Juliusson S, Pipkorn U, Karlsson G, Enerbäck L. Mast cells and cosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 1992;90:898-909.
9. Naclerio RM, Baroody FM, Kagey-Sobotka A, Lichtenstein LM. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol 1994;94:1303-1309.
10. Bentley AM, Jacobsen MR, Cumberworth V, et al. Immunohistology of the nasal mucosa in seasonal rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992;89:877-883.
11. Klementsson H, Svensson C, Andersson M, et al. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991;21:705-710.
12. Pipkorn U, Karlsson G, Enerbäck L. The cellular response of the human allergic mucosa to natural allergen exposure. J Allergy Clin Immunol 1988;82:1046-1054.
13. Iliopoulus O, Baroody FM, Naclerio RM, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Histamine containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 1992;148:2223-2228.
14. Guo C-B, Liu MC, Galli SJ, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. The histamine containing cells in the late phase response to antigen in the lung are basophils. Am J Respir Cell Mol Biol 1994;10:384-390.
15. Armitage JM, Sin Fai Lam K, Wilkinson I, Faux JA, Hopkin JM. Investigation of the tendency to wheeze in pollen sensitive patients. Clin Exp Allergy 1992;22:916-922.
16. Somville MA, Machiels J, Gilles JGG, Saint-Remy JR. Seasonal variation in specific IgE antibodies of grass-pollen hypersensitive patients depends on the steady state IgE concentration and is not correlated to clinical symptoms. J Allergy Clin Immunol 1989;83:486-494.
17. Dieguez I, Sanz ML, Ochling A. Influence of immunotherapy on histamine release and other immunological parameters of immediate hypersensitivity in pollinosis. J Investig Allergol Clin Immunol 1993;3:64-71.
18. Carlson M, Håkansson L, Kämpe M, et al. Degranulation of cosinophils from pollen atopic patients with asthma is increased during pollen season. J Allergy Clin Immunol 1992;89:131-139.
19. Carlson M, Håkansson L, Peterson C, Stålenheim G, Venge P. Secretion of granule proteins from cosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991;87:27-33.
20. Rak S, Björnson A, Håkansson L, Sörenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88:878-888.
21. Tommasini M, Magrini L, De Petrillo G, et al. Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure. J Allergy Clin Immunol 1996;97:1350-1353.
22. Poulsen LK, Reimert CM, Bindslev-Jensen C. In vitro release of eosinophil proteins in allergic and atopic dermatitis patients. Mediators Inflamm 1994;3:223-227.
23. Reimert CM, Poulsen LK, Bindslev-Jensen C, Kharazmi A, Bendtzen K. Measurement of eosinophil cationic protein [ECP] and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Time and temperature dependent spontaneous release in vitro demands standardized sample processing. J Immunol Methods 1993;166:183-190.
24. Reimert CM, Venge P, Kharazmi A, Bendtzen K. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Methods 1991;138:285-290.
25. Nolte H, Schiøtz O, Skov PS. A new glass microfibre-based histamine analysis for allergy testing in children. Results compared with conventional leukocyte histamine release assay, skin prick test, bronchial provocation test and RAST. Allergy 1987;42:366-373.
26. Skov PS, Jensen C, Nolte H, Mosbech H, Norn S. Regulatory role of cell-bound IgE on histamine release. Drug receptors and dynamic processes in cells. In: Schou JS, Geisler A, Norn S, editors. Alfred Benzon Symposium 22. Copenhagen: Munksgaard, 1986:245-254.
27. Geladi P, Kowalski BR. Partial least square regression: a tutorial. Anal Chim Acta 1986;185:1-17.
28. Moseholm L. Analysis of air pollution plant exposure data: the soft independent modelling of class analogy [SIMCA] and partial least square modelling with latent variable [PLS] approaches. Environ Pollut 1988;53:313-331.
29. Marone G, Spadaro G, Patella V, Genovese A. The clinical relevance of basophil releasability. J Allergy Clin Immunol 1994;94:1293-1302.
30. MacGlashan D. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993;91:605-615.
31. Ohnishi T, Sur S, Collins DS, Fish JE, Gleich GJ, Peters SP. Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challenge. J Allergy Clin Immunol 1993;92:607-615.
32. Rasp G, Thomas PA, Bujía J. Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum. Clin Exp Allergy 1994;24:1151-1156.
33. Schleimer RP, Bochner BS. The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994;94:1202-1213.
34. Pokkens WJ, Vroom TM, Rijntjes E, Mulder PGH. Fluctuation of the number of CD-1 [T6]-positive dendritic cells, presumably Langerhans cells, in the nasal mucosa of patients with an isolated grass-pollen allergy before during, and after the grass-pollen season. J Allergy Clin Immunol 1989;84:39-43.
35. Canonica GW. Role of adhesion molecules in the pathophysiology of allergy. Allergy Clin Immunol News 1994;Suppl 3:8-10.
36. Ciprandi G, Pronzato C, Ricca V, et al. Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54 on nasal epithelial cells in allergic subjects. J Respir Crit Care Med 1994;150:1653-1659.